Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001753926-24-000518)

Filing Details

Accession Number:: 0001753926-24-000518
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2024-03-12 16:05:51
Reporting Period:: 2024-02-21

Accepted Time:: 2024-03-12 16:05:51
Original Submission Date:: 2024-02-21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1919246	Chromocell Therapeutics Corp	CHRO	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1679440	M Ezra Friedberg	C/O Chromocell Therapeutics Corporation 4400 Route 9 South, Suite 1000 Freehold NJ 07728		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-02-21	16,667	$6.00	545,721	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This Form 4/A is being filed to include the purchase of 16,667 shares of the Issuer's common stock (the "Common Stock") in the Issuer's initial public offering, in addition to the securities originally reported on the Form 4 filed by the reporting person on February 21, 2024.